Samuel S. Streeterhttps://orcid.org/0000-0001-8267-3556,1,2 Jason R Gunn,1 Meaghan T. Hart,3 Niles P. Donegan,4 Ambrose Cheung,2 Kevin S. McIver,3 Jonathan T. Elliott,1,2 Eric R Henderson,1,2 Logan M. Bateman1
1Dartmouth-Hitchcock Medical Ctr. (United States) 2Dartmouth College (United States) 3Univ. of Maryland, College Park (United States) 4U.S. Dept. of Veterans Affairs (United States)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Necrotizing soft-tissue infections (NSTIs) are aggressive and deadly. A major obstacle to prompt NSTI management is the lack of a definitive diagnostic test, causing treatment delays and increasing mortality. NSTI-affected tissues undergo prominent blood vessel thrombosis invisible to the naked eye that can be rapidly visualized using perfusion-based fluorescence imaging. To validate fluorescence imaging for rapid NSTI detection, we are developing a preclinical mouse model of NSTI using light-producing strains of causative bacteria that have biological equivalence to wild type. Co-registration of our wide-field fluorescence imagery with spectrally distinct, bacterial bioluminescence provides validation of infection presence and spatial extent.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Samuel S. Streeter, Jason R Gunn, Meaghan T. Hart, Niles P. Donegan, Ambrose Cheung, Kevin S. McIver, Jonathan T. Elliott, Eric R Henderson, Logan M. Bateman, "Preclinical modeling of perfusion-based fluorescence imaging for the detection of life-threatening necrotizing soft-tissue infections," Proc. SPIE PC12822, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2024, PC1282205 (13 March 2024); https://doi.org/10.1117/12.2691480